Skip to main content
SpringerLink
Log in

Towards a Vaccine Against AIDS: Lessons from Simian Immunodeficiency Virus Vaccines

  • Chapter
Simian Immunodeficiency Virus

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 188))

Abstract

The discovery in 1983 that HIV-1 is the causative agent of AIDS stimulated a widespread search for an animal model in which prophylactic vaccines and therapeutic approaches could be assessed. A wide range of mammals, including several species of non-human primates, were inoculated with strains of HIV-1 (Gibbs et al. 1986). It soon appeared that only chimpanzees and gibbon apes were susceptible to infection by HIV-1. However, their use in AIDS research was severely limited because these animals are rare and protected species. Furthermore, persistently infected chimpanzees did not appear to develop the characteristic clinical signs of AIDS. Alternative animal models for AIDS and HIV infection in man were sought.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agy MB, Frumkin LR, Corey L, Coombs RW, Wolinsky SM, Koehler J, Morton WR, Katze MG (1992) Infection of Macaca nemestrina by human immunodeficiency virus type 1. Science 257: 103–106

    Article  PubMed  CAS  Google Scholar 

  • Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, Chermann J-C, Henderson LE (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258: 1935–1938

    Article  PubMed  CAS  Google Scholar 

  • Azocar J, Essex M (1979) Incorporation of HLA antigens into the envelope of RNA tumour viruses grown in human cells. Cancer Res 39: 3388–3391

    PubMed  CAS  Google Scholar 

  • Benveniste RE, Morton WR, Clark EA, Tsai C-C, Ochs HD, Ward JM, Kuller L, Knott WB, Hill RW, Gale MJ, Thouless ME (1988) Inoculation of baboons and macaques with simian immunodeficiency virus/mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol 62: 2091–2101

    PubMed  CAS  Google Scholar 

  • Bubbers JR, Lilly F (1977) Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature 266: 458–459

    Article  PubMed  CAS  Google Scholar 

  • Carlson JR, McGraw TP, Keddie E, Yee JL, Rosenthal A, Langlois AJ, Dickover R, Donovan R, Luciw PA, Jennings MB, Gardner MB (1990) Vaccine protection of rhesus macaques against simian immunodeficiency virus infection. AIDS Res Hum Retroviruses 6:1239–1246

    PubMed  CAS  Google Scholar 

  • Chan WL, Rodgers A, Hancock R, Taffs F, Kitchin P, Farrar G, Liew FY (1992) Protection in SIV-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med 176: 1203–1207

    Article  PubMed  CAS  Google Scholar 

  • Cranage MP, Baskerville A, Ashworth LAE, Dennis M, Cook N, Sharpe S, Farrar G, Rose J, Kitchin PA, Greenaways PJ (1992a) Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 339: 273–274

    Article  PubMed  CAS  Google Scholar 

  • Cranage MP, Ashworth LAE, Greenaway PJ, Murphy-Corb M, Desrosiers R (1992b) AIDS vaccine development. Nature 355: 685–686

    Article  PubMed  CAS  Google Scholar 

  • Cranage MP, Polyanskaya N, McBride B, Cook N, Ashworth LAE, Dennis M, Baskerville A, Greenaway PJ, Corcoran T, Kitchin P, Rose J, Murphey-Corb M, Desrosiers RC, Stott EJ, Farrar G H (1993) Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses 9: 13–22

    Article  PubMed  CAS  Google Scholar 

  • Daniel MD, Letvin NL, King NW Jr, Kannagi M, Sehgal PK, Kanki PJ, Essex M and Desrosiers RC (1985) Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228: 1201–1204.

    Article  PubMed  CAS  Google Scholar 

  • Daniel MD, Kirchoff F, Czajak SC, Sehgal PK, Desrosiers RC (1992) Protective efforts of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258: 1938–1941

    Article  PubMed  CAS  Google Scholar 

  • Desrosiers RC (1990) A finger on the missing link. Nature 345: 288–289

    Article  PubMed  CAS  Google Scholar 

  • Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, Daniel MD (1989) Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci USA 86: 6353–6357

    Article  PubMed  CAS  Google Scholar 

  • Fukasawa M, Miura T, Hasegawa A, Morikawa S, Tsujimoto H, Miki K, Kitamura T, Hayami M (1988) Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV-SIV group. Nature 333: 457–461

    Article  PubMed  CAS  Google Scholar 

  • Fultz PN, McClure HM, Anderson DC, Swenson RB, Anand R, Srinivasan A (1986) Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci USA 83: 5286–5290

    Article  PubMed  CAS  Google Scholar 

  • Gardner MB, Murphey-Corb M (1990) Vaccine protection of rhesus monkeys against homologous and heterologous strains of SIV. In: Grard M, Valette L (eds) Cinquieme Colloque des Cent Gardes. Fondation Marcel Merieux, Lyon pp 221–226

    Google Scholar 

  • Gardner MB, Jennings M, Carlson JR, Lerche N, McGraw T, Luciw P, Marx P, Pedersen N (1989) Postexposure immunotherapy of simian immunodeficiency virus (SIV) infected rhesus with an SIV immunogen. J Med Primatol 18: 321–328

    Google Scholar 

  • Gelderblom H, Reupke H, Winkel T, Kunze R, Pauli G (1987) MHC antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Z Naturforsch (C) 42: 1328–1334

    CAS  Google Scholar 

  • Giavedoni LP, Planelles V, Haigwood NL, Ahmed S, Kluge JD, Marthas ML, Gardner MB, Luciw PA, Yilma TD (1993) Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol 67: 577–583

    PubMed  CAS  Google Scholar 

  • Gibbs CJ, Gajdusek DC, Epstein LG, Asher DM, Goudsmit J (1986) In: Salzman LA (ed) Animal models of retrovirus infection and their relationship to AIDS. Academic, London, pp 457–462

    Google Scholar 

  • Henderson LE, Sowder R, Copeland TD, Oroszlan S, Arthur LO, Robey WG, Fischinger PJ (1987) Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol 61: 629–632

    PubMed  CAS  Google Scholar 

  • Hoxie JA, Fitzharris TP, Youngbar PR, Matthews DM, Rackowski JL, Radka SF (1987) Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol 18:39–52

    Article  PubMed  CAS  Google Scholar 

  • Hu S-L, Abrams K, Barber GN, Moran P, Zarling JM, Langlois AJ, Kuller LR, Morton WR, Benveniste RE, (1992a) Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255: 456–459

    Article  PubMed  CAS  Google Scholar 

  • Hu S-L, Travis BM, Stallard V, Abraams K, Mischer L, Moran P, Zarling JM, Langlois AL, Kuller L, Morton WR, Benveniste RE (1992b) Immune responses to SIVmne envelope glycoproteins protect against macaques from homologus SIV infection. AIDS Res Hum Retroviruses 8: 1489–1494

    PubMed  CAS  Google Scholar 

  • Johnson PR, Montefiori DC, Goldstein S, Hamm TE, Zhou J, Kitov S, Haigwood NL, Misher L, London WT, Gerin JL, Allison A, Purcell RH, Chanock RM, Hirsch VM (1992a) Inactivated wholevirus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc Natl Acad Sci USA 89: 2175–2179

    Article  PubMed  CAS  Google Scholar 

  • Johnson PR, Montefiori DE, Goldstein S, Hamm TE, Zhon J, Kitov S, Haigwood NL, Misher London WT, Gerin JL, Allison A, Purcell RH, Chanock RM, Hirsch VM (1992b) Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus infected cells. AIDS Res Hum Retroviruses 8: 1501–1505

    Article  PubMed  CAS  Google Scholar 

  • Kent K, Rud E, Corcoran T, Powell C, Thiriart C, Collignon C, Stott EJ (1992) Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. Aids Res Hum Retroviruses 8: 737–741

    Article  Google Scholar 

  • Kent KA, Kitchin P, Mills KHG, Page M, Taffs LF, Corcoran T, Silvera P, Flanagen B, Powell C, Rose J, Ling C, Aubertin AM, Stott EJ (1994) Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protected against challenge with SIVmac251. AIDS Res Hum Retroviruses 10: 189–194

    Article  PubMed  CAS  Google Scholar 

  • Kestler HW, Li Y, Naidu M, Butler CV, Ochs MF, Jaenel G, King NW, Daniel MD, Desrosiers RC (1988) Comparison of simian immunodeficiency virus isolates. Nature 331: 619–620

    Article  PubMed  Google Scholar 

  • Langlois AJ, Weinhold KJ, Matthews TH, Greenberg ML, Bolognesi DP (1992) Detection of antihuman cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 8: 1641–1652

    Article  PubMed  CAS  Google Scholar 

  • Le Grand R, Vogt G, Vaslin B, Roques P, Theodoro F, Aubertin A-M, Dormont D (1992) Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 10: 873–879

    Article  PubMed  Google Scholar 

  • Letvin NL, Eaton KA, Aldrich WR, Sehgal PK, Blake BJ, Schlossman SF, King NW, Hunt RD (1983) Acquired immunodeficiency syndrome in a colony of macaque monkeys. Proc Natl Acad Sci USA 80: 2718–2722

    Article  PubMed  CAS  Google Scholar 

  • Letvin NL, Daniel MD, Sehgal PK, Desrosiers RC, Hunt RD, Waldron LM, MacKey JJ, Schmidt DK, Chalifoux LV, King NW (1985) Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230: 71–73

    Article  PubMed  CAS  Google Scholar 

  • Lewis MG, Elkins WR, McCutchan EF, Benveniste RE, Lai CY, Montefiori DC, Burke DS, Eddy GA, Schafferman A (1993) Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine 11:1347–1355

    Article  PubMed  CAS  Google Scholar 

  • Li J, Lord CI, Haseltine W, Letvin NL, Sodroski (1992) Infection of cynomolgus macaques with a chimearic HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoprotein. J Acquir Immune Defic Syndr 5: 639–646

    PubMed  CAS  Google Scholar 

  • Lowenstine LJ, Pedersen NC, Higgins J, Pallis KC, Uyeda A, Marx PA, Lerche NW, Munn RJ, Gardner MB (1986) Seroepidemiologic servey of captive Old World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer 38: 563–575

    Article  PubMed  CAS  Google Scholar 

  • Marthas ML, Sutjipto S, Higgins J, Lohman B, Torten J, Luciou PA, Marx PA, Redersen NC (1990) Immunization with a live attenuated simian immunodeficiency virus (SIV) presents early disease, but not infection in rhesus macaques challenged with pathogenic SIV. J Virol 64: 3694–3700

    PubMed  CAS  Google Scholar 

  • Mills KHG, Barnard AL, Williams M, Page M, Ling C, Stott EJ, Silvera P, Taffs LF, Kingsman AS, Adams SE, Almond N, Kitchin PA, Jones WC (1991) Vaccine induced CD4+ T-cells against the simian immunodeficiency virus gag protein. J Immunol 147: 3560–3567

    PubMed  CAS  Google Scholar 

  • Mills KHG, Page M, Chan WL, Kitchin P, Stott EJ, Taffs LF, Jones W, Rose J, Ling C, Silvera P, Corcoran T, Flanagan B, Burny A, Bex F, Delchambre M, Van Opstal 0, Fabry L, Thiriart C, Delers A, DeWilde M, Bruck C (1992) Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone but not with BK28- derived recombinant env and gag proteins. J Med Primatol 21: 50–58

    PubMed  CAS  Google Scholar 

  • Mills KHG, Page M, Kitchin P, Chan WL, Jones W, Silvera P, Corcoran T, Flanagan B, Ling C, Thiriart C, DeWilde M, Bruck C, Rud E, Clarke B, Stott EJ (1993) Immunization of macaques with SIV env recombinants: specificity of T-cell and antibody responses and evaluation of protective efficacy. J Med Primatol (in press)

    Google Scholar 

  • Murphey-Corb M, Martin LN, Rangan SRS, Baskin GB, Gormus BJ, Wolf RH, Andes WA, West M (1986) Isolation of an HTLV-III retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature 321: 435–437

    Article  PubMed  CAS  Google Scholar 

  • Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro C, Miller M, West M, Ohkawa S, Baskin GB, Zhang J-Y, Putney SD, Allison AC, Eppstein DA (1989) A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246: 1293–1297

    Article  PubMed  CAS  Google Scholar 

  • Murphy-Corb M, Montelaro RC, Miller MA, West M, Martin LN, Davison-Fairburn B, Ohkawa S, Baskin, Zlang JY, Miller GB (1991) Efficacy of SIV/dalta B670 glycoprotein enriched and glycoprotein depleted subunit vaccines in protecting against infection and disease in rhesus monkeys. AIDS 5: 655–662

    Article  Google Scholar 

  • Murphy-Corb M, Ohkawa S, Davison-Fairburn B, Martin LN, Baskin GB, Langlois AJ, Mclntee M, Narayan O, Gardner MB (1992) A formalin-fixed whote SIV vaccine induces protective responses that are cross protective and durable. AI DS Res Hum Retroviruses 8:1475–1478

    Google Scholar 

  • Ohta Y, Masuda T, Tsujimoto H, Ishikawa K-I, Kodama T, Morikawa S, Nakai M, Honjo S, Hayami M (1988) isolation of simian immunodeficiency virus from African green monkeys and seroepidemiology survey of the virus in various non-human primates. Int J Cancer 41: 115–122

    Article  PubMed  CAS  Google Scholar 

  • Osterhaus A, de Vries P, Morein B, Akerblom L, Heeney J (1992) Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted fromalin-inactivated SIV vaccines from i.v. cell-free or cell-associated homologous challenge. AIDS Res Hum Retroviruses 8: 1507–1510

    PubMed  CAS  Google Scholar 

  • Prakash K, Ranganathan PN, Methus R, Reddy P, Srinivasan A, Plotkin (1992) Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration. J Virol 66:167–171

    CAS  Google Scholar 

  • Putkonen P, Thorstensson R, Albert J, Hild K, Norrby E, Biberfeld P, Biberfeld G (1990) infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 4: 783–789

    Article  PubMed  CAS  Google Scholar 

  • Putkonen P, Thorstensson R, Walther L, Albert J, Akerblom L, Granquist O, Wadell G, Norby E, Biberfeld G (1991a) Vaccine protection against HIV-2 infection in cynomolgus monkey. AIDS Res Hum Retroviruses 7: 271–277

    Article  PubMed  CAS  Google Scholar 

  • Putkonen P, Thorstensson R, Ghavamzadeh L, Albert J, Hild K, Biberfeld G etal. (1991b) Prevention of HIV-2 and SIV infection by passive immunization in cynomolgus monkeys. Nature 352: 436–438

    Article  PubMed  CAS  Google Scholar 

  • Putkonen P, Thorstensson R, Cranage M, Nilsson C, Ghavamzadeh L, Albert J, Greenaway P, Biberfeld G (1992) A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge. J Med Primatol 21: 108–112

    PubMed  CAS  Google Scholar 

  • Rud EW, Yon JR, Larder BA, Cook N, Cranage MP, Clarke BE (1992) Infectious molecular clones of SIVmac 32H: nef deletion controls ability to reisolate virus from rhesus macaques. In: Brown F et al. (eds) Vaccines 92: modern approaches to new vaccines including prevention of AIDS. Cold Sping Harbor Laboratory Press, New York, pp 229–235

    Google Scholar 

  • Sakuragi S, Schibata R, Mukai R, Komatsu T, Kukasawa M (1992) Infection of macaque monkeys with a chimearic human and simian immunodeficiency virus. J Gen Virol 73: 2983–2987

    Article  PubMed  CAS  Google Scholar 

  • Shafferman A, Jährling PB, Benviniste RE, Lewis MG, Phipps TJ, Edin-McCutchan F, Sadoff J, Eddy GA, Burke DS (1991) Protection of macaques with an SIV envelope peptide vaccine based on conserved HIV-1 sequences. Proc Natl Acad Sci USA 88: 7126–7130

    Article  PubMed  CAS  Google Scholar 

  • Shafferman A, Lewis MG, McCutchan FE, Benveniste RE, Jährling PB, Burke DS, Eddy GA (1993) Prevention of transmission of simian immunodeficiency virus from vaccinated macaques that developed transient virus infection following challenge. Vaccine (in press)

    Google Scholar 

  • Shibata R, Kawamura M, Sakai H, Hayami, M, Ishimoto A, Adachi A (1991) Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol 65: 3514–3520

    PubMed  CAS  Google Scholar 

  • Stahl-Hennig C, Voss G, Dittmer V, Coulibaly C, Petry H, Luke W, Hunsmann G (1993) Protection of monkeys by a split vaccine against SIVmac depends on biological properties of the challenge virus. AIDS (in press)

    Google Scholar 

  • Stott EJ, Chan WL, Mills KHG, Page M, Taffs F, Cranage M, Greenaway P, Kitchin PA (1990) Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by a whole fixed cell vaccine. Lancet 336: 1538–1541

    Article  PubMed  CAS  Google Scholar 

  • Stott EJ, Cranage MP, Kitchin PA, Kent K, Farrar G, Taffs LF (1991a) Vaccination against simian immunodeficiency virus infection of macaques. In: Girard M, Valette L (eds) Sixieme Colloque des Cent Gardes. Fondation Marcel Merieux, Lyon, p. 261–266

    Google Scholar 

  • Stott EJ, Kitchin PA, Page M, Flanagan B, Taffs LF, Chan WL, Mills KHG, Silvera P, Rodger A (1991b) Anti-cell antibody in macaques. Nature 353: 393

    Article  PubMed  CAS  Google Scholar 

  • Sutjipto S, Pedersen NC, Miller CJ, Gardner MB, Hanson CV, Gettie A, Jennings M, Higgins J, Marx PA (1990) Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J Virol 64: 2290–2297

    PubMed  CAS  Google Scholar 

  • Tsujimoto H, Cooper RW, Kodama T, Fukasawa M, Miura T, Ohta Y, Ishikawa Kl, Nakai M, Frost E, Roelants GE, Roffi J, Hayami M (1988) Isolation and characterisation of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses. J Virol 62: 4044–4050

    PubMed  CAS  Google Scholar 

  • Voss G, Stahl-Hennig C, Petry H, Coulibaly C, Nick S, Fuschs D, Wächter H, Luke W, Hunsmann G (1992) Immunization of rhesus monkeys with high and low dose Tween-ether disrupted SIVmac. AIDS Res Hum Retroviruses 8: 1397–1400

    PubMed  CAS  Google Scholar 

  • Watanabe M, Levine CG, Shen CG, Fisher RA, Letvin NL (1991) Immunisation of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response. Proc Natl Acad Sci USA 88: 4616–4620

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK

    E. J. Stott

Authors
  1. E. J. Stott
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New England Regional Primate Research Center, Harvard Medical School, One Pine Hill Drive, Southborough, MA, 01772-9102, USA

    Norman L. Letvin M.D.  & Ronald C. Desrosiers Ph.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stott, E.J. (1994). Towards a Vaccine Against AIDS: Lessons from Simian Immunodeficiency Virus Vaccines. In: Letvin, N.L., Desrosiers, R.C. (eds) Simian Immunodeficiency Virus. Current Topics in Microbiology and Immunology, vol 188. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78536-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78536-8_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78538-2

  • Online ISBN: 978-3-642-78536-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation